Trial Profile

Evaluation of 124I-p5+14 Injection as an Imaging Agent for the Detection of Systemic Amyloidosis

Status: Completed

Phase of Trial: Phase I/II

Latest Information Update: 14 Nov 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs AT 01 (Primary)
Indications Amyloid light-chain amyloidosis; Amyloidosis
Focus Diagnostic use; First in man

Most Recent Events

07 Nov 2023 Results published in the Media Release
07 Nov 2023 According to an Attralus media release, data from this study were published in the Journal of American College of Cardiology - Cardiovascular Imaging (JACC CV Imaging).
02 Oct 2023 Results presented in an Attralus media release.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com